Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125740422 | 12574042 | 2 | F | 2015 | 20160805 | 20160720 | 20160816 | EXP | IT-JNJFOC-20160712705 | JANSSEN | POGLIANI D, POZZI A, LAUDI C, RIMOLDI L, SOGNI E, FARFAGLIA P, ET AL. NONCONVULSIVE STATUS EPILEPTICUS DUE TO FENANTYL INTOXICATION IN HEMODIALYZED PATIENTS: TWO CASE REPORTS AND REVIEW OF THE LITERATURE. ITALIAN JOURNAL OF NEPHROLOGY 2016;33 (3):1-10. | 81.95 | YR | E | F | Y | 0.00000 | 20160816 | OT | IT | IT |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125740422 | 12574042 | 1 | SS | FENTANYL. | FENTANYL | 1 | Transdermal | Y | N | 0 | MATRIX PATCH | ||||||||
125740422 | 12574042 | 2 | PS | FENTANYL. | FENTANYL | 1 | Transdermal | Y | N | 19813 | MATRIX PATCH | ||||||||
125740422 | 12574042 | 3 | I | RIFAMPICIN | RIFAMPIN | 1 | Unknown | U | 0 | 300 | MG | UNSPECIFIED | QD | ||||||
125740422 | 12574042 | 4 | C | FENTANYL. | FENTANYL | 1 | Unknown | 0 | 100 | UG | TABLET | ||||||||
125740422 | 12574042 | 5 | C | FENTANYL. | FENTANYL | 1 | Unknown | 0 | 200 | UG | TABLET | ||||||||
125740422 | 12574042 | 6 | C | LEVOFLOXACIN. | LEVOFLOXACIN | 1 | Oral | 0 | UNSPECIFIED | ||||||||||
125740422 | 12574042 | 7 | C | LEVOFLOXACIN. | LEVOFLOXACIN | 1 | Oral | 0 | UNSPECIFIED | ||||||||||
125740422 | 12574042 | 8 | C | VANCOMYCIN | VANCOMYCIN | 1 | Other | 0 | 500 | MG | UNSPECIFIED | ||||||||
125740422 | 12574042 | 9 | C | VANCOMYCIN | VANCOMYCIN | 1 | Other | 0 | 1 | G | UNSPECIFIED |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125740422 | 12574042 | 1 | Pain management |
125740422 | 12574042 | 2 | Pain management |
125740422 | 12574042 | 3 | Product used for unknown indication |
125740422 | 12574042 | 4 | Product used for unknown indication |
125740422 | 12574042 | 5 | Product used for unknown indication |
125740422 | 12574042 | 6 | Product used for unknown indication |
125740422 | 12574042 | 7 | Product used for unknown indication |
125740422 | 12574042 | 8 | Staphylococcus test positive |
125740422 | 12574042 | 9 | Staphylococcus test positive |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125740422 | 12574042 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125740422 | 12574042 | Drug interaction | |
125740422 | 12574042 | Overdose | |
125740422 | 12574042 | Status epilepticus | |
125740422 | 12574042 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125740422 | 12574042 | 1 | 20150602 | 0 | ||
125740422 | 12574042 | 2 | 20150521 | 0 |